Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

MLA

Walsh, Stephen R., et al. “Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087): A Phase I Randomized Clinical Trial.” PLoS Medicine, vol. 21, no. 6, June 2024, p. e1004329. EBSCOhost, https://doi.org/10.1371/journal.pmed.1004329.

APA

Walsh, S. R., Gay, C. L., Karuna, S. T., Hyrien, O., Skalland, T., Mayer, K. H., Sobieszczyk, M. E., Baden, L. R., Goepfert, P. A., del Rio, C., Pantaleo, G., Andrew, P., Karg, C., He, Z., Lu, H., Paez, C. A., Baumblatt, J. A. G., Polakowski, L. L., Chege, W., … Mascola, J. R. (2024). Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial. PLoS Medicine, 21(6), e1004329. https://doi.org/10.1371/journal.pmed.1004329

Chicago

Walsh, Stephen R., Cynthia L. Gay, Shelly T. Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer, Magdalena E. Sobieszczyk, et al. 2024. “Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087): A Phase I Randomized Clinical Trial.” PLoS Medicine 21 (6): e1004329. doi:10.1371/journal.pmed.1004329.